HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zoledronic acid(ZOMETA): a significant improvement in the bone metastases.

AuthorsZsuzsanna Nagy
JournalPathology oncology research : POR (Pathol Oncol Res) Vol. 11 Issue 3 Pg. 186-7 ( 2005) ISSN: 1219-4956 [Print] Switzerland
PMID16299941 (Publication Type: Journal Article)
Chemical References
  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid
Topics
  • Bone Density Conservation Agents (therapeutic use)
  • Bone Neoplasms (drug therapy, secondary)
  • Clinical Trials as Topic
  • Diphosphonates (therapeutic use)
  • Humans
  • Imidazoles (therapeutic use)
  • Neoplasm Metastasis (drug therapy)
  • Zoledronic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: